Comparison of the Distribution of Three Bisphosphonates in Mice
- 1 April 1990
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 66 (4) , 294-298
- https://doi.org/10.1111/j.1600-0773.1990.tb00750.x
Abstract
The distribution of approximately equipotent doses of14C‐labelled clodronate (0.1 mmol/kg), etidronate (0.1 mmol/kg), and amidronate (0.015 mmol/kg), and also an equimolar dose of amidronate (0.1 mmol/kg), was studied in mice by measuring the14C‐activities in various tissues up to 360 days after a single intravenous injection. With the higher dose of amidronate the distribution could be, however, monitored only for 7 days because of the toxicity of the drug. The results indicate that there are major differences in the deposition of the bisphosphonates into soft tissues, while the disappearance from plasma and incorporation into bone are quite similar in terms of percentage of dose per g of tissue. However, the binding capacity of bone for clodronate and etidronate is many times greater than that for amidronate expressed as nmol of the drug per g of tissue. Amidronate deposits in the spleen and liver of mice, when injected in saline, whereas clodronate and etidronate do not. This agrees with the suggestion that amidronate, but not the other two, can interfere with the mononuclear phagocyte system of spleen and liver.This publication has 16 references indexed in Scilit:
- A One Year Follow‐Up Study of the Distribution of 14C‐Clodronate in Mice and RatsBasic & Clinical Pharmacology & Toxicology, 1988
- The acute-phase response after bisphosphonate administrationCalcified Tissue International, 1987
- Inhibition of bone matrix apposition by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (AHPrBP) in the mouseBone, 1985
- Diphosphonates: History and mechanisms of actionMetabolic Bone Disease and Related Research, 1981
- Apd in paget's disease of bone role of the mononuclear phagocyte system?Arthritis & Rheumatism, 1980
- TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- Uptake by Bone of Pyrophosphate, Diphosphonates and their Technetium DerivativesClinical Science, 1978
- The comparative effects of dichloromethylene diphosphonate (Cl2MDP) and ethane-1-hydroxy-1,1-diphosphonate (EHDP) on growth and modeling of the rat tibiaCalcified Tissue International, 1977
- The Influence of Two Diphosphonates on Calcium Metabolism in the RatClinical Science, 1972
- Metabolism of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) in the rat, rabbit, dog and monkeyToxicology and Applied Pharmacology, 1972